TrialThe Journal of clinical endocrinology and metabolism2015

Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study.

Mario Salvi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.